Oncopeptides participated at BioStock Investing in Life Science

Oncopeptides’ CFO Henrik Bergentoft and Director of IR and Communications David Augustsson recently participated at BioStock’s Investing in Life Science event in Stockholm.

Henrik presented Oncopeptides and answered questions from the audience and moderator. The presentation can be found below, in English.

Earlier in the day, David participated in a panel together with Bita Sehat, Partner at Trill Impact, Johan Emilsson, CEO at Sprint Bioscience on the challenges and opportunities for Nordic biotechs to tell their stories to the global investor landscape. The discussion was moderated by Jonas Söderström, CEO at Biostock.

Watch the panel discussion below, in English.